Zobrazeno 1 - 10
of 93
pro vyhledávání: '"R. Zschaber"'
Autor:
Rita Maria Alves, Paolo Uva, Marielza F. Veiga, Manuela Oppo, Fabiana C. R. Zschaber, Giampiero Porcu, Henrique P. Porto, Ivana Persico, Stefano Onano, Gianmauro Cuccuru, Rossano Atzeni, Lauro C. N. Vieira, Marcos V. A. Pires, Francesco Cucca, Maria Betânia P. Toralles, Andrea Angius, Laura Crisponi
Publikováno v:
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background KBG syndrome is a very rare autosomal dominant disorder, characterized by macrodontia, distinctive craniofacial findings, skeletal findings, post-natal short stature, and developmental delays, sometimes associated with seizures an
Externí odkaz:
https://doaj.org/article/22adc8b7ac914df3a0cf5814817a5e60
Autor:
Rossano Atzeni, Henrique P. Porto, Lauro C. N. Vieira, Manuela Oppo, Maria Betânia Pereira Toralles, Andrea Angius, Marielza Veiga, Rita Maria Alves, Fabiana C. R. Zschaber, Stefano Onano, Gianmauro Cuccuru, Paolo Uva, Laura Crisponi, Marcos V. A. Pires, Giampiero Porcu, Francesco Cucca, Ivana Persico
Publikováno v:
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-7 (2019)
BMC Medical Genetics
BMC Medical Genetics
Background KBG syndrome is a very rare autosomal dominant disorder, characterized by macrodontia, distinctive craniofacial findings, skeletal findings, post-natal short stature, and developmental delays, sometimes associated with seizures and EEG abn
Publikováno v:
Acta Oto-Laryngologica. 121:647-651
Autor:
D. Uthgenannt, R. Seeger, R. Zschaber, H. Merz, T. Wagner, Susanna Hegewisch-Becker, Alfred C. Feller, J.H. Hartlapp, H.J. Illiger, G.J. Wiedemann, Peter Reichardt, Elke Jäger, K. Weber, O. Löwenstrom, Mathias Freund
Publikováno v:
Oncology Research and Treatment. 22:134-138
SummaryTrofosfamide (TROFO) is an orally taken oxazaphosphorine prodrug. Other metabolic products of TROFO include ifosfamide and cyclophosphamide. In pilot studies with TROFO, significan
Autor:
R. Zschaber, W. Schultze, P. Reitzig, B. Knutzen, G.J. Wiedemann, Johannes Drach, Kurt Possinger, G. Herzog, B. Kilpert, Peter Reichardt, N. Zojer, Michael Stahl, B. Kaluza, S. Hansen, F.A. Muthny, Clemens Unger, A. Dietzmann, H. Merz, W. Dornoff, Tahar Benhidjeb, R. Stecker, K. Mross, E. Richter, T. Wagner, Hannes Kaufmann, Elke Jäger, Michael Fiegl, D. Uthgenannt, R. Seeger, Peter M. Schlag, B. Brockmann, Mathias Freund, Susanna Hegewisch-Becker, A.A. Fauser, Alfred C. Feller, V. Briese, T. Feyerabend, H.J. Illiger, K. Mücke, J. Nowicki, B. Rodi, J.H. Hartlapp, O. Löwenstrom, Stefan Fuxius, K. Weber
Publikováno v:
Oncology Research and Treatment. 22:85-91
Autor:
R. Zschaber, William Krüger, A.R. Zander, Nicolaus Kröger, K. Mross, W. Zeller, D.K. Hossfeld
Publikováno v:
Oncology Research and Treatment. 18:419-428
The availability of hematopoietic growth factors, autologous bone marrow, and peripheral blood stem cells has led to numerous clinical studies in breast cancer studying the dose response of chemotherapy. Significant higher remission rate by increasin
Publikováno v:
Laryngo-Rhino-Otologie. 71:370-374
Therapy of large inoperable squamous cell-carcinomas of the head and neck is considerably problemful. Combined simultaneous radio-chemotherapy with carboplatin and radiotherapy with hyperfractionated accelerated radiation is small effective than conv
Autor:
P. Reitzig, Kurt Possinger, T. Feyerabend, Clemens Unger, E. Richter, Susanna Hegewisch-Becker, A.A. Fauser, G.J. Wiedemann, W. Schultze, T. Wagner, Hannes Kaufmann, K. Mross, F.A. Muthny, Alfred C. Feller, Johannes Drach, Peter Reichardt, O. Löwenstrom, D. Uthgenannt, R. Seeger, N. Zojer, H. Merz, S. Hansen, W. Dornoff, B. Rodi, K. Mücke, B. Kilpert, B. Knutzen, J.H. Hartlapp, Mathias Freund, A. Dietzmann, B. Kaluza, R. Stecker, Michael Fiegl, J. Nowicki, H.J. Illiger, Peter M. Schlag, Tahar Benhidjeb, B. Brockmann, Michael Stahl, Stefan Fuxius, K. Weber, G. Herzog, Elke Jäger, R. Zschaber, V. Briese
Publikováno v:
Oncology Research and Treatment. 22:154-156
SummaryUm Leitlinien fur die adjuvante Therapie bei Kolon- und Rektumkarzinom zu erstellen, haben Vertreter der CAO, der AIO und der ARO am 11. 03.1994 einen Konsens erarbeitet; dieser wu
Autor:
Clemens Unger, N. Zojer, K. Mücke, W. Schultze, E. Richter, T. Wagner, Hannes Kaufmann, J.H. Hartlapp, Mathias Freund, O. Löwenstrom, H. Merz, Michael Fiegl, W. Dornoff, Peter M. Schlag, B. Knutzen, Johannes Drach, Peter Reichardt, B. Kaluza, Susanna Hegewisch-Becker, A.A. Fauser, K. Mross, S. Hansen, B. Brockmann, B. Kilpert, G. Herzog, F.A. Muthny, Alfred C. Feller, D. Uthgenannt, R. Seeger, B. Rodi, R. Zschaber, H.J. Illiger, Michael Stahl, T. Feyerabend, J. Nowicki, Stefan Fuxius, K. Weber, V. Briese, Elke Jäger, A. Dietzmann, P. Reitzig, Kurt Possinger, G.J. Wiedemann, R. Stecker, Tahar Benhidjeb
Publikováno v:
Oncology Research and Treatment. 22:150-152
[Clinical presentation, therapy and prognosis of non-Hodgkin lymphomas of the major salivary glands]
Publikováno v:
Laryngo- rhino- otologie. 80(12)
About 5 - 10 % of all Non-Hodgkin-Lymphomas (NHL) present within the major salivary glands. Two etio-pathologically different groups, the (extranodal)-parenchymal NHL and NHL of intra- or periglandular lymphnodes (nodal lymphomas) have to be distingu